Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) (PALMIRA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03809988
Recruitment Status : Recruiting
First Posted : January 18, 2019
Last Update Posted : May 14, 2019
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
MedSIR

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2022
  Estimated Study Completion Date : January 2023